Speech-Language Pathologists in Taneytown, MD Accepting Medicare

2 Speech-Language Pathologists found. Showing 1 - 2

Mrs. Anastasia Slovikosky, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17 Monocacy Cir, Taneytown, MD 21787 Phone: 410-599-4095

Melanie Caitlin Scherer, M.S. CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Antrim Blvd, Taneytown, MD 21787 Phone: 888-479-1161

News Archive

Universal HIV treatment, if achieved, would not mean eradication of AIDS

In this post in BMJ's "Yankee Doodling," Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation "if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment."

SPO Medical signs MOU with MetroSleep

SPO Medical Inc., a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, today announced it has signed a Memorandum of Understanding (MOU) with MetroSleep Inc, a US corporation that specializes in products to diagnose and treat sleep apnea through at-home testing. The MOU enables the integration of SPO Medical' ASIC chip-set technology in a new MetroSleep product offering for the Sleep Disturbance Breathing monitoring market.

Nurses who work the night shift more likely to have poor sleep habits

Nurses who work the night shift are more likely to have poor sleep habits, a practice that can increase the likelihood of committing serious errors that can put the safety of themselves as well as their patients at risk, according to research presented at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).

Study suggests that circadian factors may contribute to suicidality

A new study provides novel evidence suggesting that suicides are far more likely to occur between midnight and 4 a.m. than during the daytime or evening.

Lexicon announces pricing of underwritten public offering of common stock

Lexicon Pharmaceuticals, Inc. today announced the pricing of its previously announced underwritten public offering of $50,000,000 of shares of its common stock pursuant to an effective shelf registration statement.

Read more Medical News

› Verified 6 days ago